Crossmark

Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up

Published Online: 2021-07-29

Published Print: 2021-12

Authors

Vilela, Verônica Silva

Dias, Marcio Macri

Salgado, Ângelo Antunes

da Silva, Bruno Rangel Antunes

Lopes, Agnaldo José

Bessa, Elizabeth Jauhar Cardoso

Bruno, Leonardo Palermo

da Costa, Cláudia Henrique

Levy, Roger Abramino

Rufino, Rogério https://orcid.org/0000-0002-5071-6045
Funding

Funding for this research was provided by:

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E26/202.931/2019)
License Information

Text and Data Mining valid from 2021-07-29

Version of Record valid from 2021-07-29
More Information

Article History

Received: 28 July 2020

Accepted: 26 July 2021

First Online: 29 July 2021

Declarations

:

: The study was approved by the local ethics committee (Pedro Ernesto University Hospital, From the State University of Rio de Janeiro, Ethics Committee 314092). All patients signed written informed consent. The study was registered on the Brazilian Clinical Trials Platform (Brazil Platform 16739013.4.0000.5259) on the March 19th of 2013.

: Not applicable.

: RAL is a full employee at GSK. The other authors declare no conflicts of interest.

Document is current